These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2186673)
1. Efficacy and safety of intranasal budesonide in the treatment of perennial rhinitis in adults and children. Day JH; Andersson CB; Briscoe MP Ann Allergy; 1990 May; 64(5):445-50. PubMed ID: 2186673 [TBL] [Abstract][Full Text] [Related]
2. A double blind comparison of intranasal budesonide 400 micrograms and 800 micrograms in perennial rhinitis. Wight RG; Jones AS; Beckingham E; Andersson B; Ek L Clin Otolaryngol Allied Sci; 1992 Aug; 17(4):354-8. PubMed ID: 1526057 [TBL] [Abstract][Full Text] [Related]
3. A clinical comparison of intranasal budesonide with beclomethasone dipropionate for perennial non-allergic rhinitis: a 12 month study. Synnerstad B; Lindqvist N Br J Clin Pract; 1996; 50(7):363-6. PubMed ID: 9015907 [TBL] [Abstract][Full Text] [Related]
4. A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis. Andersson M; Berglund R; Greiff L; Hammarlund A; Hedbys L; Malcus I; Nilsson P; Olsson P; Sjölin IL; Synnerstad B Rhinology; 1995 Mar; 33(1):18-21. PubMed ID: 7784789 [TBL] [Abstract][Full Text] [Related]
5. Intranasal budesonide for the treatment of perennial rhinitis in Thai patients. Bunnag C; Dhorranintra B; Jareoncharsri P Asian Pac J Allergy Immunol; 1988 Dec; 6(2):116-20. PubMed ID: 3219158 [TBL] [Abstract][Full Text] [Related]
6. Budesonide aqueous nasal spray and pressurized metered dose inhaler in the treatment of adult patients with seasonal allergic rhinitis. Day J; Alexander M; Drouin M; Frankish C; Mazza J; Moote W; Patel P; Ramsdale H; Yang W Am J Rhinol; 1997; 11(1):77-83. PubMed ID: 9065352 [TBL] [Abstract][Full Text] [Related]
7. Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis. A 12-month multicentre study. Lindqvist N; Balle VH; Karma P; Kärjä J; Lindström D; Mäkinen J; Pukander J; Ruoppi P; Suonpää J; Ostlund W Allergy; 1986 Apr; 41(3):179-86. PubMed ID: 3521382 [TBL] [Abstract][Full Text] [Related]
8. A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis. Brown K; Lane J; Silva MP; DeTineo M; Naclerio RM; Baroody FM Int Forum Allergy Rhinol; 2014 Jan; 4(1):43-8. PubMed ID: 24574125 [TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Chervinsky P; Kunjibettu S; Miller DL; Prenner BM; Raphael G; Hall N; Shah T Ann Allergy Asthma Immunol; 2007 Jul; 99(1):69-76. PubMed ID: 17650833 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the efficacy and patient acceptability of budesonide and beclomethasone dipropionate aqueous nasal sprays in patients with perennial rhinitis. Adamopoulos G; Manolopoulos L; Giotakis I Clin Otolaryngol Allied Sci; 1995 Aug; 20(4):340-4. PubMed ID: 8548967 [TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled study of the effect of intranasal budesonide in the treatment of children with seasonal rhinitis. Wolthers OD; Jørgensen BA; Pedersen S Acta Paediatr; 1992 Nov; 81(11):902-6. PubMed ID: 1467613 [TBL] [Abstract][Full Text] [Related]
12. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours. Fokkens WJ; Cserháti E; dos Santos JM; Praca F; van Zanten M; Schade A; Simon G Ann Allergy Asthma Immunol; 2002 Sep; 89(3):279-84. PubMed ID: 12269648 [TBL] [Abstract][Full Text] [Related]
13. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis. Möller C; Ahlström H; Henricson KA; Malmqvist LA; Akerlund A; Hildebrand H Clin Exp Allergy; 2003 Jun; 33(6):816-22. PubMed ID: 12801318 [TBL] [Abstract][Full Text] [Related]
14. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine. Stern MA; Wade AG; Ridout SM; Cambell LM Ann Allergy Asthma Immunol; 1998 Oct; 81(4):354-8. PubMed ID: 9809500 [TBL] [Abstract][Full Text] [Related]
15. Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children. Wolthers OD; Pedersen S Allergy; 1994 Feb; 49(2):96-9. PubMed ID: 8172365 [TBL] [Abstract][Full Text] [Related]
16. Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol. Gastpar H; Aurich R; Petzold U; Dorow P; Enzmann H; Gering R; Köchy HP; Philippe A; Renz W; Wendenburg G Arzneimittelforschung; 1993 Apr; 43(4):475-9. PubMed ID: 8494580 [TBL] [Abstract][Full Text] [Related]
17. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis. Meltzer EO Ann Allergy Asthma Immunol; 1998 Aug; 81(2):128-34. PubMed ID: 9723557 [TBL] [Abstract][Full Text] [Related]
18. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Juniper EF; Guyatt GH; Andersson B; Ferrie PJ Ann Allergy; 1993 Mar; 70(3):225-30. PubMed ID: 8452318 [TBL] [Abstract][Full Text] [Related]
19. Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis. Kivisaari E; Baker RC; Price MJ Clin Exp Allergy; 2001 Jun; 31(6):855-63. PubMed ID: 11422149 [TBL] [Abstract][Full Text] [Related]
20. A comparison of aqueous suspensions of budesonide nasal spray (128 micrograms and 256 micrograms once daily) and fluticasone propionate nasal spray (200 micrograms once daily) in the treatment of adult patients with seasonal allergic rhinitis. Stern MA; Dahl R; Nielsen LP; Pedersen B; Schrewelius C Am J Rhinol; 1997; 11(4):323-30. PubMed ID: 9292184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]